摘要:
Neutralcopper complexes, particularly copper-salicylate complexes.having the formula Cu[C 6 H 4 (OH)COO] 2 ROH in which ROH represents an alkanol, have been found to have therapeutic activity in the treatment of inflammatory diseases. The complexes have been found particularly suitable for the treatment of arthritis.
摘要:
Neutral copper complexes, particularly copper salicylate complexes having the formula Cu[C 6 H 4 (OH)COO] 2 γ in which y is dimethyl sulphoxide or dimethylformamide, have been found to have therapeutic activity in the treatment of inflammatory diseases and copper deficiency conditions. The complexes have been found particularly suitable for the treatment of Menkes' syndrome.
摘要:
Neutral copper complexes, particularly copper salicylate complexes having the formula Cu[C 6 H 4 (OH)COO] 2 γ in which y is dimethyl sulphoxide or dimethylformamide, have been found to have therapeutic activity in the treatment of inflammatory diseases and copper deficiency conditions. The complexes have been found particularly suitable for the treatment of Menkes' syndrome.